Unpacking the Latest Options Trading Trends in Eli Lilly

Large investors, often referred to as "whales," have shown a strong positive outlook on Eli Lilly (NYSE: LLY). A review of the recent options trading history for Eli Lilly revealed a total of 71 trades.

Looking closer at these trades, we find that approximately 46% of the investors entered trades with a bullish perspective, while 36% took a bearish approach. This indicates a noticeable trend towards optimism among some traders regarding the stock's future performance.

Among the trades executed, there were 44 puts, totaling around $2,707,496, and 27 calls amounting to about $4,083,731.

What's The Price Target?

When analyzing the volume and open interest associated with these contracts, it appears that major players in the market are anticipating a price range for Eli Lilly between $300.00 and $1000.00 in the upcoming quarter.

Analyzing Volume & Open Interest

Currently, the mean open interest for Eli Lilly options trades stands at approximately 448.32, with a total trade volume recorded at 4,764.00. The chart below illustrates the changes in volume and open interest for both call and put options on Eli Lilly's significant trades within the identified strike price range over the past 30 days.

Eli Lilly Call and Put Volume: 30-Day Overview

Here, we can observe the latest trends in options trading specific to Eli Lilly.

Noteworthy Options Activity:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
LLY	CALL	TRADE	BEARISH	12/19/25	$51.9	$46.9	$48.0	$1000.00	$2.4M	620	1
LLY	PUT	SWEEP	BULLISH	03/21/25	$30.2	$29.85	$29.85	$840.00	$262.6K	508	339
LLY	CALL	TRADE	BEARISH	03/21/25	$25.0	$24.65	$24.65	$825.00	$123.2K	6	55
LLY	PUT	SWEEP	BEARISH	03/21/25	$32.1	$31.55	$32.1	$840.00	$105.9K	508	441
LLY	PUT	SWEEP	BEARISH	03/14/25	$76.25	$74.05	$75.0	$895.00	$97.5K	687	43

About Eli Lilly

Eli Lilly is a pharmaceutical company that specializes in various therapeutic areas, including neuroscience, cardiometabolic issues, cancer, and immunological diseases. Their significant products include Verzenio for cancer treatment, Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic care, as well as Taltz and Olumiant for immunological treatments.

After reviewing the options trading activities related to Eli Lilly, let’s turn our attention to the company’s current performance.

Where Is Eli Lilly Standing Right Now?

• Currently, Eli Lilly's trading volume is at 759,402, with the stock price down by approximately -0.77%, trading at around $823.41.
• Relative Strength Index (RSI) values suggest that the stock may be nearing an oversold condition.
• The next earnings report is expected in about 51 days.

What The Experts Say On Eli Lilly

In the last month, one industry analyst has provided insights regarding Eli Lilly stock, suggesting an average target price of $1100.00.

Turn $1000 into $1270 in just 20 days?

A seasoned options trader with 20 years of experience has revealed a unique one-line chart technique that indicates the best times to buy and sell. Following their trades has resulted in an average profit of 27% approximately every 20 days.

For real-time updates on options trading for Eli Lilly, feel free to use available platforms to follow the latest market trends.

investing, trading, EliLilly